Chimeric homeobox gene E2A-PBX1 induces proliferation, apoptosis, and malignant lymphomas in transgenic mice

[1]  M. Lieberman,et al.  Differentiation of CD3-4-8- thymocytes in short-term thymic stromal cell culture , 1992, The Journal of experimental medicine.

[2]  K. M. Abraham,et al.  Thymic tumorigenesis induced by overexpression of p56lck. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[3]  David Baltimore,et al.  A new homeobox gene contributes the DNA binding domain of the t(1;19) translocation protein in pre-B all , 1990, Cell.

[4]  M. Cleary,et al.  PBX2 and PBX3, new homeobox genes with extensive homology to the human proto-oncogene PBX1 , 1991, Molecular and cellular biology.

[5]  F. Behm,et al.  Different Molecular Consequences of the 1;19 Chromosomal Translocation in Childhood B - Cell Precursor Acute Lymphoblastic Leukemia , 1992 .

[6]  T. Kadesch,et al.  Two distinct transcription factors that bind the immunoglobulin enhancer microE5/kappa 2 motif. , 1990, Science.

[7]  M. Scott,et al.  The structure and function of the homeodomain. , 1989, Biochimica et biophysica acta.

[8]  A. W. Harris,et al.  The E mu-myc transgenic mouse. A model for high-incidence spontaneous lymphoma and leukemia of early B cells , 1988, The Journal of experimental medicine.

[9]  E2A-Pbx1, the t(1;19) translocation protein of human pre-B-cell acute lymphocytic leukemia, causes acute myeloid leukemia in mice. , 1993, Molecular and cellular biology.

[10]  C. Murre,et al.  A new transcriptional-activation motif restricted to a class of helix-loop-helix proteins is functionally conserved in both yeast and mammalian cells , 1993, Molecular and cellular biology.

[11]  R. Warnke,et al.  Advantages of detecting monoclonal antibody binding to tissue sections with biotin and avidin reagents in Coplin jars. , 1986, American journal of clinical pathology.

[12]  Gerard I. Evan,et al.  Induction of apoptosis in fibroblasts by c-myc protein , 1992, Cell.

[13]  M. Cleary.  Oncogenic conversion of transcription factors by chromosomal translocations , 1991, Cell.

[14]  I. Weissman,et al.  Purification and characterization of mouse hematopoietic stem cells. , 1988, Science.

[15]  I. Weissman,et al.  An immunodominant murine lymphoma cell surface heterodimer marks thymic progenitor subsets. , 1990, Journal of immunology.

[16]  M. Cleary,et al.  Molecular analysis of the t(1;19) breakpoint cluster region in pre‐b cell acute lymphoblastic leukemias , 1990, Genes, chromosomes & cancer.

[17]  I. Weissman,et al.  IgH enhancer deregulated expression of L‐myc: abnormal T lymphocyte development and T cell lymphomagenesis. , 1990, The EMBO journal.

[18]  T. McDonnell,et al.  Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14;18) , 1991, Nature.

[19]  G. Evan,et al.  Cooperative interaction between c-myc and bcl-2 proto-oncogenes , 1992, Nature.

[20]  A. Strasser,et al.  Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2 , 1990, Nature.

[21]  D. Green,et al.  Apoptotic cell death induced by c-myc is inhibited by bcl-2 , 1992, Nature.

[22]  David Baltimore,et al.  A new DNA binding and dimerization motif in immunoglobulin enhancer binding, daughterless, MyoD, and myc proteins , 1989, Cell.

[23]  Michael L. Cleary,et al.  Chromosomal translocation t(1;19) results in synthesis of a homeobox fusion mRNA that codes for a potential chimeric transcription factor , 1990, Cell.

[24]  T. Rabbitts,et al.  T-cell acute lymphoblastic lymphoma induced in transgenic mice by the RBTN1 and RBTN2 LIM-domain genes. , 1992, Oncogene.

[25]  T. Blankenstein,et al.  A retroviral expression vector containing murine immunoglobulin heavy chain promoter/enhancer. , 1988, Nucleic acids research.

[26]  J. Sklar,et al.  Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation , 1986, Cell.

[27]  Suzanne Cory,et al.  bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship , 1991, Cell.

[28]  S. Smith,et al.  The gene for enhancer binding proteins E12/E47 lies at the t(1;19) breakpoint in acute leukemias. , 1989, Science.

[29]  J. Tilly,et al.  Epidermal growth factor and basic fibroblast growth factor suppress the spontaneous onset of apoptosis in cultured rat ovarian granulosa cells and follicles by a tyrosine kinase-dependent mechanism. , 1992, Molecular endocrinology.

[30]  J. Shuster,et al.  Predictability of the t(1;19)(q23;p13) from surface antigen phenotype: implications for screening cases of childhood acute lymphoblastic leukemia for molecular analysis: a Pediatric Oncology Group study. , 1993, Blood.

[31]  E. White,et al.  Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B. , 1993, Genes & development.

[32]  D. Vaux,et al.  Enforced BCL2 expression in B-lymphoid cells prolongs antibody responses and elicits autoimmune disease. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[33]  A T Look,et al.  The human t(1;19) translocation in pre-B ALL produces multiple nuclear E2A-Pbx1 fusion proteins with differing transforming potentials. , 1991, Genes & development.

[34]  R. Palmiter,et al.  The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice , 1985, Nature.

[35]  R. Parmley,et al.  Pre-B cell leukemia associated with chromosome translocation 1;19. , 1984, Blood.

[36]  F. Alt,et al.  IgH enhancer‐mediated deregulation of N‐myc gene expression in transgenic mice: generation of lymphoid neoplasias that lack c‐myc expression. , 1989, The EMBO journal.

[37]  P Chambon,et al.  Isolation of high-molecular-weight DNA from mammalian cells. , 1973, European journal of biochemistry.

[38]  S. Lowe,et al.  Stabilization of the p53 tumor suppressor is induced by adenovirus 5 E1A and accompanies apoptosis. , 1993, Genes & development.

[39]  S. Korsmeyer,et al.  bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes , 1991, Cell.

[40]  T. Rabbitts.  Translocations, master genes, and differences between the origins of acute and chronic leukemias , 1991, Cell.

[41]  David L. Vaux,et al.  Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells , 1988, Nature.

[42]  M. Loken,et al.  Simultaneous analysis of DNA content and surface antigens in human bone marrow. , 1988, Cytometry.

[43]  A. W. Harris,et al.  The c-myc oncogene perturbs B lymphocyte development in Eμ-myc transgenic mice , 1986, Cell.

[44]  J. Cleveland,et al.  Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis. , 1991, Oncogene.

[45]  S. Korsmeyer,et al.  bcl-2-Immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation , 1989, Cell.

[46]  I. Weissman,et al.  T cell receptor-mediated negative selection of autoreactive T lymphocyte precursors occurs after commitment to the CD4 or CD8 lineages , 1990, The Journal of experimental medicine.

[47]  A. Berns,et al.  Predisposition to lymphomagenesis in pim-1 transgenic mice: Cooperation with c-myc and N-myc in murine leukemia virus-induced tumors , 1989, Cell.

[48]  G. Sclar,et al.  Thymic overexpression of Ttg-1 in transgenic mice results in T-cell acute lymphoblastic leukemia/lymphoma , 1992, Molecular and cellular biology.

[49]  A. Wyllie,et al.  Cell death: the significance of apoptosis. , 1980, International review of cytology.

[50]  D. Baltimore,et al.  Introduction of a μ immunoglobulin gene into the mouse germ line: Specific expression in lymphoid cells and synthesis of functional antibody , 1984, Cell.

[51]  S. Cory,et al.  Transgenic models of tumor development. , 1991, Science.